Figure 3

Frequency of immune cell populations analyzed from peripheral blood (PB) throughout the trial.

(a) NKT-cells as a proportion of CD3⁺ lymphocytes, (b) CD3⁺ cells as a proportion of lymphocytes, (c) CD4⁺ single positive T cells as a proportion of CD3⁺ lymphocytes, (d) CD8α⁺ single positive T cells as a proportion of CD3⁺ lymphocytes, (e) double positive CD4⁺ CD8α⁺ T cells as a proportion of CD3⁺ lymphocytes, (f) γδ T cells as a proportion of CD3⁺ lymphocytes, (g) NK cells (CD3⁻ CD8α⁺) as a proportion of lymphocytes, (h) CD172α⁺ cells as a proportion of leukocytes. Differences in PB immune cell populations were analyzed using the SAS PROC MIXED procedure and no treatment differences were identified. Data are represented as mean ± SEM.